Cyanosis epidemiology and demographics

Cyanosis Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cyanosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cyanosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cyanosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cyanosis epidemiology and demographics
CDC on Cyanosis epidemiology and demographics
Cyanosis epidemiology and demographics in the news
Blogs on Cyanosis epidemiology and demographics
Directions to Hospitals Treating Cyanosis
Risk calculators and risk factors for Cyanosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]

Epidemiology and Demographics

• The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide.
• Data about the incidence of cyanotic congenital heart disease is inadequate.

Age

• Congenital cyanotic heart disease is more commonly observed among neonates.

Gender

• Congenital cyanotic heart disease affects men and women equally.

Race

• There is no racial predilection for cyanotic congenital heart disease.